VACCINE POLICY RECOMMENDATION

File: 121096_sep96_decls22_0001.txt
Page: 0001
Total Pages: 3

Subject: VACCINE POLICY RECOMMENDATION                                   

Unit: OTSG        

Parent Organization: HSC         

Box  ID: BX003203

Folder Title: VACCINE POLICY RECOMMENDATION                                                                   

Document Number:          1

Folder Seq  #:        241


                                         UNCLASSIFIED



                                  DEPARTMENT OF THE ARMY
                                  OFFICE OF THE SURGEON GENERAL
                                      5109 LEESBURG PIKE
                                   FALLS CHURCH, VA 22041-3258
                REPLY TO
                A@ENTION OF

          SGPS-ZA (50)


          MEMORANDUM FOR OFFICE OF THE DEPUTY CHIEF OF STAFF FOR
                            OPERATIONS AND PLANS, WASHINGTON, DC 20310

          SUBJECT: Vaccine Policy Recommendation


          1. (U) Reference: Memorandum, HQDA (ODCSOPS), DAMO-SW,
          9 September 1991, Subject: Minutes of the Biological Defense
          Committee Meeting, 29 August 1991, Memorandum 3-9-1. (U)

          2. (U) This memorandum provides information for ODCSOPS and
          the Biological Defense Committee to make a vaccine policy
          recommendation.


          3.        The facts are:

                          In FY92, the United States can only vaccinate
                  'Service Members (SM) against anthrax                gainst
          botulinum.
                                                5 USC 522(b)(1)
                b.        In FY93, an additional          SM can be vaccinated
          against anthrax. The level of production of botulinum toxoid in
          FY93 is uncertain.

                C.        By FY94, increased production of both vaccines will
          begin.

                    (1)        The Army indemnified the National Cancer
          Institute (NCI) for the production of anthrax. Production
          estimates should allow DoD to protect            SM per year against
          anthrax. (NCI production rate estimated to
          doses per year.)

                          (a) (U) This allows Michigan Department of Public
          Health (MDPH) to transfer its effort to produce botulinum toxoid.

                          (b)       The combined production effort of Porton,
earch Institute of Infectious Diseases and
          MDPH is expected to yield enough vaccine to protect             SMs
          against botulinum per year. (Production rate estimated
          doses per year.)                                          5 USC 522(b)(1)
      5 USC 522(b)(1)(2)       Based on current projections, a vaccinated
                                                          for botulinum can
          be maintained by FY97. These projections are based on maximum

                 DECLASSIFIED
                 ON: 26 NOV 96                        LED@
        CLASSIFIED BY: SECiARMYu@MH) qiMIAW@T4-tU 12958
        DECLASSIFY ON: OADR

Document 3 f:/Week-36/BX003203/VACCINE POLICY RECOMMENDATION/vaccine policy recommendation:12069615355523
Control Fields 17
File Room = sep96_declassified
File Cabinet = Week-36
Box ID = BX003203
Unit = OTSG
Parent Organization = HSC
Folder Title = VACCINE POLICY RECOMMENDATION
Folder Seq # = 241
Subject = VACCINE POLICY RECOMMENDATION
Document Seq # = 1
Document Date =
Scan Date =
Queued for Declassification = 01-JAN-1980
Short Term Referral = 01-JAN-1980
Long Term Referral = 01-JAN-1980
Permanent Referral = 01-JAN-1980
Non-Health Related Document = 01-JAN-1980
Declassified = 06-DEC-1996